Urology · San Antonio, TX
NPI
1922088947
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
18915 Meisner Dr
San Antonio, TX, 78258
Phone (210) 499-5158
Groups this clinician bills Medicare through
Medicare paid, 2024
$447K
15,437 services
Medicare patients, 2024
1,143
Average age 76
Drug cost, 2024
$9.7M
5,446 prescriptions
Company payments, 2025
$56K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel R Saltzstein was code J0897 (injection, denosumab, 1 mg), 4,620 times for 27 patients. In total Daniel R Saltzstein billed 15,437 services in 95 codes, and Medicare paid $447K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,620 | 27 | $19.97 | $92K |
| 87798 Infectious Agent Detection by DNA/RNA | Office | 1,224 | 80 | $34.39 | $42K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,149 | 763 | $11.73 | $13K |
| 99214 Office E&M - Established | Office | 929 | 591 | $86.69 | $81K |
| 81001 Clinical Chemistry | Office | 922 | 659 | $3.08 | $2,841 |
| 84153 Clinical Chemistry | Office | 858 | 581 | $18.00 | $15K |
| 51798 Ultrasound - Nonspecific | Office | 704 | 548 | $7.05 | $4,960 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 605 | 98 | $44.43 | $27K |
| 84403 Clinical Chemistry | Office | 490 | 273 | $25.29 | $12K |
| 99213 Office E&M - Established | Office | 322 | 294 | $56.66 | $18K |
| 85027 Blood Count | Office | 182 | 117 | $6.34 | $1,154 |
| 80048 Clinical Chemistry | Office | 181 | 113 | $8.29 | $1,500 |
| 36415 Venipuncture Blood Collection | Office | 173 | 152 | $8.55 | $1,479 |
| 52000 Cystourethroscopy | Office | 118 | 104 | $166.99 | $20K |
| 87481 Infectious Agent Detection by DNA/RNA | Office | 102 | 80 | $34.39 | $3,508 |
By year: 2022 $818K for 37,707 services; 2023 $581K for 22,440 services; 2024 $447K for 15,437 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87798 Infectious Agent Detection by DNA/RNA | 1,224 | 80 | $34.39 | $42K |
| 81001 Clinical Chemistry | 922 | 659 | $3.08 | $2,841 |
| 84153 Clinical Chemistry | 858 | 581 | $18.00 | $15K |
| 84403 Clinical Chemistry | 490 | 273 | $25.29 | $12K |
| 85027 Blood Count | 182 | 117 | $6.34 | $1,154 |
| 80048 Clinical Chemistry | 181 | 113 | $8.29 | $1,500 |
| 36415 Venipuncture Blood Collection | 173 | 152 | $8.55 | $1,479 |
| 87481 Infectious Agent Detection by DNA/RNA | 102 | 80 | $34.39 | $3,508 |
| 87653 Infectious Agent Detection by DNA/RNA | 102 | 80 | $34.39 | $3,508 |
| 87640 Infectious Agent Detection by DNA/RNA | 102 | 80 | $34.39 | $3,508 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel R Saltzstein prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,136 prescriptions and refills. In total Daniel R Saltzstein wrote 5,446 Medicare prescriptions that cost $9.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,136 | 2,777 | 308 | $17K |
| Finasteride Generic | 818 | 2,288 | 241 | $11K |
| Orgovyx Relugolix | 644 | 646 | 83 | $1.6M |
| Erleada Apalutamide | 275 | 276 | 34 | $3.7M |
| Myrbetriq Mirabegron | 233 | 395 | 68 | $177K |
| Abiraterone Acetate Generic | 206 | 206 | 23 | $420K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 204 | 529 | 52 | $3,935 |
| Prednisone Generic | 191 | 199 | 23 | $1,160 |
| Xtandi Enzalutamide | 144 | 144 | 23 | $2.0M |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 127 | 247 | 54 | $4,151 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 124 | 228 | 30 | $1,999 |
| Ciprofloxacin Hcl Generic | 117 | 129 | 89 | $566 |
| Trimethoprim Generic | 92 | 189 | 31 | $5,534 |
| Cephalexin Generic | 90 | 192 | 31 | $987 |
| Nubeqa Darolutamide | 83 | 83 | Under 11 | $1.1M |
Brand drugs: 1,607 claims; generic drugs: 3,839 claims; opioid claims: 95.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel R Saltzstein $56K ($54K in general payments such as food, travel and fees and $1,270 for research) from 22 companies. The largest payer was Janssen Biotech, Inc. with $14K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 14 | $14K |
| Pfizer Inc. PFE | 14 | $8,288 |
| Astellas Pharma US Inc 4503.T | 3 | $6,393 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $6,355 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $5,365 |
| Telix Pharmaceuticals TLX | 12 | $4,838 |
| Sumitomo Pharma America, Inc. 4506.T | 9 | $3,852 |
| Ferring Pharmaceuticals Inc. | 1 | $2,415 |
| Urogen Pharma, Inc. URGN | 4 | $2,409 |
| Dendreon Pharmaceuticals LLC | 5 | $1,160 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.